Replies to post #163 on Boston Scientific Corp (BSX)

[conix]

BSX Chart

[conix]

Boston Scientific launches WaveWriter Alpha spinal cord stimulator in the U.S.

Jan. 14, 2021

Boston Scientific (BSX +0.3%) has announced a limited market release of the WaveWriter Alpha portfolio of Spinal Cord Stimulator (SCS) systems.
It includes unified portfolio of four MRI conditional, Bluetooth-enabled rechargeable and non-rechargeable implantable pulse generators, to provide Fast Acting Sub-perception Therapy designed to deliver profound paresthesia-free pain relief in minutes.

The systems are supported by the Cognita Solutions suite of digital tools for patients and physicians.

The WaveWriter Alpha SCS Systems were approved by the FDA in December 2020 and is indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs including unilateral or bilateral pain associated with failed back surgery syndrome, Complex Regional Pain Syndrome Types I and II, intractable low back pain and leg pain.